These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6373477)

  • 61. Serum glucagon and cystatin C levels with renal doppler sonography findings in non-azotemic liver cirrhosis cases.
    Ustundag Y; Hekimoğlu K; Ilikhan S; Zaimoğlu G; Acikgöz S; Aydemir S
    Hepatogastroenterology; 2011; 58(107-108):926-31. PubMed ID: 21830418
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.
    Ginès P; Titó L; Arroyo V; Llach J; Salmerón JM; Ginès A; Jiménez W; Badalamenti S; Rivera F; Rodés J
    Gastroenterology; 1992 Jan; 102(1):280-6. PubMed ID: 1290472
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term effects of intracerebroventricular insulin microinjection on renal sodium handling and arterial blood pressure in rats.
    Menegon LF; Zaparolli A; Boer PA; de Almeida AR; Gontijo JA
    Brain Res Bull; 2008 Jul; 76(4):344-8. PubMed ID: 18502308
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sodium excretion in advanced cirrhosis: effect of expansion of central blood volume and suppression of plasma aldosterone.
    Nicholls KM; Shapiro MD; Kluge R; Chung HM; Bichet DG; Schrier RW
    Hepatology; 1986; 6(2):235-8. PubMed ID: 3957232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites.
    Woitas RP; Flommersfeld S; Stoffel-Wagner B; Schiedermaier P; Brensing KA; Spengler U; Sauerbruch T
    Scand J Gastroenterol; 2002 Nov; 37(11):1321-7. PubMed ID: 12465732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention.
    Ros J; Fernández-Varo G; Muñoz-Luque J; Arroyo V; Rodés J; Gunnet JW; Demarest KT; Jiménez W
    Br J Pharmacol; 2005 Nov; 146(5):654-61. PubMed ID: 16113688
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of refractory cardiac insufficiency with infusion of glucagon, insulin, glucose and potassium].
    Castaldi C; D'Amore F; Materia E; Mauceri M; Rivosecchi L
    Minerva Cardioangiol; 1978 Nov; 26(11):751-6. PubMed ID: 724124
    [No Abstract]   [Full Text] [Related]  

  • 69. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
    Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP
    Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis.
    Ibarra FR; Afione C; Garzon D; Barontini M; Santos JC; Arrizurieta E
    Eur J Clin Pharmacol; 1992; 43(5):477-82. PubMed ID: 1483484
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.
    Bernardi M; Servadei D; Trevisani F; Rusticali AG; Gasbarrini G
    Digestion; 1985; 31(4):189-93. PubMed ID: 4007290
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
    Mansurov KhKh; Dustov AD
    Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
    Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
    Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure.
    Gülberg V; Møller S; Henriksen JH; Gerbes AL
    Gut; 2000 Dec; 47(6):852-7. PubMed ID: 11076886
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Comparison of the effects of gastroenteric and parenteral saline loading on kidney function after inhibition of prostaglandin synthesis (author's transl)].
    Heuer LJ; Knue-Beestermüller E
    Res Exp Med (Berl); 1980; 178(1):43-54. PubMed ID: 7209134
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Renal, hemodynamic and hormonal effects of repeated water immersion in liver cirrhosis].
    Christoph C; Held C; Scholze HJ
    Gastroenterol J; 1990; 50(4):183-6. PubMed ID: 2151113
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Propranolol in the treatment of cirrhotic ascites.
    Rector WG; Reynolds TB
    Arch Intern Med; 1984 Sep; 144(9):1761-3. PubMed ID: 6476994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.